Tallafer, Roderick L.

HRN: 21-47-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2022
CO-AMOXICLAV 625MG (TAB)
06/21/2022
06/29/2022
ORAL
625mg/tab
BID
Infected Wound, Lateral Malleolus, Left
Waiting Final Action 
06/21/2022
MUPIROCIN 2%, 15G (TUBE)
06/21/2022
06/28/2022
TOPICAL
2%
BID
Infected Wound, Lateral Malleolus, Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: